Protalix BioTherapeutics (PLX) Finished Goods (2012 - 2026)
Protalix BioTherapeutics' Finished Goods came in at $17.96 million for Q2 2026, up 108.1% from $8.63 million a year earlier and up 16.7% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Finished Goods (2012 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics' Finished Goods was $10.37 million, up 90.4% from FY2024.
- Finished Goods carries a five-year compound annual growth rate of 8.7% (FY2020 to FY2025).
- Going back by year, Finished Goods was $5.45 million in FY2024 (-6.3%), $5.81 million in FY2023 (-45.2%), $10.62 million in FY2022 (-7.9%) and $11.53 million in FY2021 (+68.3%).
- The Q2 2026 figure represents the highest quarterly Finished Goods in data going back to Q2 2012.
- Year-over-year, Finished Goods has increased for three consecutive quarters, with growth averaging 36.0% over the last seven quarters.
- The fastest year-over-year change in Finished Goods over five years came in Q1 2026 (growth of 119.1%), and the weakest in Q3 2024 (a decline of 91.5%).
- Business Quant data shows PLX's Finished Goods at $15.38 million (Q1 2026), $10.37 million (Q4 2025) and $10.92 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.96 Mn |
| Mar 31, 2026 | 15.38 Mn |
| Dec 31, 2025 | 10.37 Mn |
| Sep 30, 2025 | 10.92 Mn |
| Jun 30, 2025 | 8.63 Mn |
| Mar 31, 2025 | 7.02 Mn |
| Dec 31, 2024 | 5.45 Mn |
| Sep 30, 2024 | 706,000.00 |
| Jun 30, 2024 | 5.54 Mn |
| Mar 31, 2024 | 9.15 Mn |
| Dec 31, 2023 | 5.81 Mn |
| Sep 30, 2023 | 8.27 Mn |
| Jun 30, 2023 | 11.97 Mn |
| Mar 31, 2023 | 14.46 Mn |
| Dec 31, 2022 | 10.62 Mn |
| Sep 30, 2022 | 8.28 Mn |
| Jun 30, 2022 | 9.91 Mn |
| Mar 31, 2022 | 10.16 Mn |
| Dec 31, 2021 | 11.53 Mn |
| Sep 30, 2021 | 8.05 Mn |
API Access
Protalix BioTherapeutics Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();